To our knowledge, our study is the first showing rational and clinical evidence that no or low levels of Cav1 expression in primary HNSCC tumors might be predictive of patient with high metastasis risk as well as being of bad prognosis. The gene discussed is CAV1; the disease is head and neck squamous cell carcinoma.